Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 6, 2019
[Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device]
Yu Sakurai
Biological & Pharmaceutical Bulletin
|
July 31, 2022
Development of siRNA Delivery System by Lipid Nanoparticles Modified with Functional Materials for Cancer Treatment
Yu Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
December 5, 2012
[Challenges and new directions for next-generation drug delivery system (DDS) research based on nano-technology]
Takayuki Ishii, Yu Sakurai
Expert Opinion on Drug Delivery
|
August 8, 2019
Hyaluronan-modified nanoparticles for tumor-targeting
Yu Sakurai, Hideyoshi Harashima
Biomaterials Science
|
August 12, 2015
Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature
Yu Sakurai, Kazuaki Kajimoto, Hideyoshi Harashima
Methods in Molecular Biology (Clifton, N.J.)
|
October 17, 2015
Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial Cells
Yu Sakurai, Tomoya Hada, Hideyoshi Harashima
International Journal of Pharmaceutics
|
November 12, 2017
Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption
Shoshiro Yamamoto, Yu Sakurai, Hideyoshi Harashima
International Journal of Molecular Sciences
|
November 24, 2019
Targeting Tumor Endothelial Cells with Nanoparticles
Yu Sakurai, Hidetaka Akita, Hideyoshi Harashima
Journal of Biomaterials Science. Polymer Edition
|
February 4, 2017
Scalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration
Yu Sakurai, Tomoya Hada, Hideyoshi Harashima
Pharmaceutics
|
September 22, 2015
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
Tomoya Hada, Yu Sakurai, Hideyoshi Harashima
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 6, 2019
[Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device]
Yu Sakurai
Biological & Pharmaceutical Bulletin
|
July 31, 2022
Development of siRNA Delivery System by Lipid Nanoparticles Modified with Functional Materials for Cancer Treatment
Yu Sakurai
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
December 5, 2012
[Challenges and new directions for next-generation drug delivery system (DDS) research based on nano-technology]
Takayuki Ishii, Yu Sakurai
Expert Opinion on Drug Delivery
|
August 8, 2019
Hyaluronan-modified nanoparticles for tumor-targeting
Yu Sakurai, Hideyoshi Harashima
Biomaterials Science
|
August 12, 2015
Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature
Yu Sakurai, Kazuaki Kajimoto, Hideyoshi Harashima
Methods in Molecular Biology (Clifton, N.J.)
|
October 17, 2015
Preparation of a Cyclic RGD: Modified Liposomal SiRNA Formulation for Use in Active Targeting to Tumor and Tumor Endothelial Cells
Yu Sakurai, Tomoya Hada, Hideyoshi Harashima
International Journal of Pharmaceutics
|
November 12, 2017
Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption
Shoshiro Yamamoto, Yu Sakurai, Hideyoshi Harashima
International Journal of Molecular Sciences
|
November 24, 2019
Targeting Tumor Endothelial Cells with Nanoparticles
Yu Sakurai, Hidetaka Akita, Hideyoshi Harashima
Journal of Biomaterials Science. Polymer Edition
|
February 4, 2017
Scalable preparation of poly(ethylene glycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration
Yu Sakurai, Tomoya Hada, Hideyoshi Harashima
Pharmaceutics
|
September 22, 2015
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
Tomoya Hada, Yu Sakurai, Hideyoshi Harashima
Page
of 8